Use of Probiotics in the Management of Hypertension - Exploring the Potential
Hypertension has become a common chronic medical condition affecting > 20% of adult population worldwide. It is certainly established to be a major contributing factor for increasing complications of metabolic syndrome by adding one or more comorbidities such as heart disease, stroke, chronic renal failure, myocardial infarction, blindness, and dementia. It is also known that hypertension is also often considered as a lifestyle disorder, and clinically classified as primary (essential) and secondary. Essential hypertension remains a major cause in about 90% - 95% of all cases of hypertension and it is believed to be caused due to genetic factors and nonspecific lifestyle, with exact aetiology and pathophysiology remains an opportunity yet to be fully defined. (1)
While by 2025, the total number of hypertensive patients is expected to increase to 1.56 billion globally (2) , emerging evidence is bringing out the important role of microbiota in hypertension and its treatment with probiotics. We review the spectrum of evidence reflecting the interplay of gut microbiota in the context of high blood pressure, hypertension associated co-morbidities and potential of probiotics in the therapeutic armamentarium of hypertension.
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email: firstname.lastname@example.org. Contact no. 011-43720751